Franklin Resources’s OnKure Therapeutics OKUR Stock Holding History

Franklin Resources’s Portfolio OKUR Stock Details OKUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-149,336	Closed	-$11.4M	–	2739
2023 Q3	$11.4M	Buy	149,336 +14,821	+11%	+$1.01M	0.01%	882
2023 Q2	$8.82M	Buy	134,515 +93,754	+230%	+$7.55M	﹤0.01%	954
2023 Q1	$2.44M	Hold	40,761	–	–	﹤0.01%	1307
2022 Q4	$950K	Hold	40,761	–	–	﹤0.01%	1530
2022 Q3	$1.36M	Hold	40,761	–	–	﹤0.01%	1449
2022 Q2	$1.08M	Sell	40,761 -90	-0.2%	-$2.1K	﹤0.01%	1521
2022 Q1	$1.2M	Sell	40,851 -4,149	-9%	-$232K	﹤0.01%	1558
2021 Q4	$3.85M	Hold	45,000	–	–	﹤0.01%	1302
2021 Q3	$3.35M	Sell	45,000 -5,000	-10%	-$424K	﹤0.01%	1312
2021 Q2	$4.67M	Buy	+50,000	New	+$5.58M	﹤0.01%	1154

Other funds holding OKUR

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

RVM

RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Franklin Resources's OKUR Position: Q4 2023 in Review

Franklin Resources sold out of OnKure Therapeutics (OKUR) in Q4 2023, closing a stake of 149,336 shares — an estimated $11.4M sold.

Franklin Resources first reported a position in OKUR in Q2 2021 and held it in 10 quarters. The position peaked at $11.4M in Q3 2023. 68 funds tracked by Wall St. Rank hold OKUR as of Q4 2023.

Franklin Resources reported no remaining OnKure Therapeutics position as of Q4 2023 after selling out during the quarter.
Franklin Resources sold 149,336 OnKure Therapeutics shares in Q4 2023, an estimated $11.4M.
Franklin Resources first reported a position in OnKure Therapeutics in Q2 2021 and held it in 10 quarters.
Franklin Resources's OnKure Therapeutics position peaked at $11.4M in Q3 2023.
68 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q4 2023.

Based on Franklin Resources's 13F filing for Q4 2023, filed 9 Feb 2024.